Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia

Experimental Biology and Medicine

Volumn 231, Issue 4, 2006, Pages 343-365

  Manukhina, Eugenia B ^a   Downey, H Fred ^b   Mallet, Robert T ^b  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Cardioprotection; Hemoglobin; Ischemia reperfusion damage; Nitric oxide stores; Nitric oxide synthase; Peroxynitrite

Indexed keywords

ANTIOXIDANT; HEAT SHOCK PROTEIN; NITRIC OXIDE; PROSTAGLANDIN;

ADAPTATION; ADRENERGIC SYSTEM; ANGIOGENESIS; BRAIN PROTECTION; CALCIUM CELL LEVEL; CARDIOVASCULAR FUNCTION; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); DISEASE DURATION; DISEASE SEVERITY; ELECTRON TRANSPORT; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEEDBACK SYSTEM; FREQUENCY MODULATION; GENE EXPRESSION; HEART PROTECTION; HUMAN; HYPERTENSION; HYPOXIA; IMMUNE RESPONSE; ISCHEMIA; LIPID METABOLISM; MALADJUSTMENT; METABOLISM; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGEN TRANSPORT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REPERFUSION INJURY; RESPIRATORY CHAIN; SHORT SURVEY; STRESS; TREATMENT OUTCOME; VASODILATATION;

EID: 33645286732     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100401     Document Type: Short Survey

References (316)

1. Hochachka PW, Monge C. Evolution of human hypoxia tolerance physiology. Adv Exp Med Biol 475:25-43, 2000.
2. Meerson FZ. Essentials of Adaptive Medicine: Protective effects of adaptation. Moscow: Hypoxia Medical LTD, 1994.
3. Zong P, Setty S, Sun W, Martinez R, Tune JD, Ehrenbourg IV, Tkatchouk EN, Mallet RT, Downey HF. Intermittent hypoxic training protects canine myocardium from infarction. Exp Biol Med 229:806-812, 2004.
4. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108:79-85, 2003.
5. Neckář J, Ošt'ádal B, Kolář F. Myocardial infarct size-limiting effect of chronic hypoxia persists for five weeks of normoxic recovery. Physiol Res 53:621-628, 2004.
6. Agadzhanyan NA, Isabaeva VA, Elfimov AI. Chemoreceptors, Hemocoagulation and High Altitude [in Russian]. Frunze: Ilim, 1973.
7. Manukhina EB, Sokolova IA, Rodionov IM. Changes in density of the vascular network on brain surface in rats in experiments hypertension and adaptation to high altitude [in Russian]. Kardiologiya 10:118, 1982.
8. Wagner PD. Skeletal muscle angiogenesis. A possible role for hypoxia. Adv Exp Med Biol 502:21-38, 2001.
9. Zhong N, Zhang Y, Zhu HF, Wang JC, Fang QZ, Zhou ZN. Myocardial capillary angiogenesis and coronary flow in ischemia tolerance rat by adaptation to intermittent high altitude hypoxia. Acta Pharmacol Sin 23:305-310, 2002.
10. LaManna JC, Chavez JC, Pichiule P. Structural and functional adaptation to hypoxia in the rat brain. J Exp Biol 207:3163-3169, 2004.
11. Burtscher M, Pachinger O, Ehrenbourg I, Mitterbauer G, Faulhaber M, Puhringer R, Tkatchouk E. Intermittent hypoxia increases exercise tolerance in elderly men with and without coronary artery disease. Int J Cardiol 96:247-254, 2004.
12. Lukyanova LD. Novel approach to the understanding of molecular mechanisms of adaptation to hypoxia. In: Hargens A, Takeda N, Singal PK, Eds. Adaptation Biology and Medicine, Volume 4: Current Concepts. New Delhi: Narosa, pp1-19, 2005.
13. Ou LC, Tenney SM. Properties of mitochondria from hearts of cattle acclimatized to high altitude. Respir Physiol 8:151-154, 1970.
14. Aleshin IA, Tin'kov AN, Kots IaI, Tverdokhlib VP. Experience in treating patients with cardiovascular diseases by means of adaptation to periodic barochamber hypoxia [in Russian]. Ter Arkh 69:54-58, 1997.
15. Meerson FZ, Tverdokhlib VP, Boev VM. Adaptation to periodic hypoxia in therapy and prophylaxis [in Russian]. Moscow: Nauka, 1989.
16. Sabdanbekov TD. Effect of hypoxic training on clinico-hemodynamic indices and physical work capacity of patients with large-focus myocardial infarct [in Russian]. Kardiologiia 27:59-62, 1987.
17. Kolchinskaya AZ, Tsyganova TN, Ostapenko LA. Normobaric Interval Hypoxic Training in Medicine and Sports [in Russian]. Moscow: Meditsina, 2003.
18. Ushakov IB, Chernyakov IN, Dvornikov MV, Shishov AA, Olenev NI, Stepanov VK, Popov VI, Kurdanov HA, Maksimova IA. Variants of interval hypobaric and normobaric hypoxic training in aviation, space and military medicine. In: Lukyanova LD, Ushakov IB, Eds. Problems of Hypoxia: Molecular, Physiological and Medical Aspects [in Russian]. Moscow: Istoki, pp411-419, 2004.
19. Tkatchouk EN, Gorbatchenkov AA, Kolchinskaya AZ, Ehrenbourg IV, Kondrykinskaya II. Adaptation to interval hypoxia for the purpose of prophylaxis and treatment. In: Meerson FZ, Ed. Esentials of Adaptive Medicine: Protective Effects of Adaptation. Moscow: Hypoxia Medical LTD, 200-221, 1994.
20. Tkatchouk EN, Makatsaria AD. Interval hypoxic training in pre- and postoperation periods as prophylaxis of postoperation complications in gynecological patients. Hypoxia Medical J (1):22-26, 1993.
21. Serebrovskaya T, Karaban I, Mankovskaya I, Bernardi L, Passino C, Appenzeller O. Hypoxic ventilatory responses and gas exchange in patients with Parkinson's disease. Respiration 65:28-32, 1998.
22. Aleshin IA, Volovich VB, Zabirov MP, Burdakov VV, Kots IaI, Meerson FZ. Effects of adaptation to periodic hypoxia on the course of idiopathic arrhythmia, microcirculation and blood coagulation [in Russian]. Kardiologiia 32:35-38, 1992.
23. Meerson FZ, Krasikov SI, Chernov AN, Tverdokhlib VP. Adaptation to periodic hypoxia limits the demand for ethyl alcohol and the withdrawal syndrome in the chronic alcoholic intoxication of animals [in Russian]. Dokl Akad Nauk SSSR 318:238-241, 1991.
24. Meerson FZ. Mechanism of phenotypic adaptation and the principles of its use for prevention of cardiovascular disorders [in Russian]. Kardiologiia 18:18-29, 1978.
25. Baker JE, Holman P, Kalyanaraman B, Griffith OW, Pritchard KA Jr. Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric oxide production. Ann N Y Acad Sci 874:236-253, 1999.
26. Manukhina EB, Malyshev IY. Role of free NO and NO stores in protective effects of adaptation to hypoxia. In: Hargens A, Takeda N, Signal PK Eds. Adaptation Biology and Medicine, Volume 4: Current Concepts. New Delhi: Narosa, pp82-94, 2005.
27. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57:217-252, 2005.
28. Chizhov AYa, Potievskaya VI. Intermittent Normobaric Hypoxia in Prevention and Treatment of Essential Hypertiension [in Russian]. Moscow: Russian University of Peoples' Friendship, 2002.
29. Bloshchinskaya IA, Davidovch IM, Parshina TA. Pregnancy, Endothelial Dysfunction, Gestosis [in Russian]. Khabarovsk: DVNIITS, 2003.
30. Meerson FZ. Adaptation, Stress and Prophylaxis. Berlin: Springer-Verlag, 1984.
31. Serebrovskaya TV, Swanson RJ, Kolesnikova EE. Intermittent hypoxia: mechanisms of action and some applications to bronchial asthma treatment. J Physiol Pharmacol 54 (Suppl 1):35-41, 2003.
32. Meerson FZ, Tverdokhlib VP, Nikonorov AA, Filippov VK, Frolov BA. The role of suppression of cholesterol 7-hydroxylase activity of the liver in the development of atherogenic stress-induced dyslipoproteinemia [in Russian]. Kardiologiia 28:85-87, 1988.
33. Neubauer JA. Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol 90:1593-1599, 2001.
34. Prabhakar NR, Kumar GK. Oxidative stress in the systemic and cellular responses to intermittent hypoxia. Biol Chem 385:217-221, 2004.
35. Row BW, Kheirandish L, Neville JJ, Gozal D. Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 52:449-453, 2002.
36. Turek Z, Hoofd L, Rakusan K. Myocardial capillaries and tissue oxygenation. Can J Cardiol 2:98-103, 1986.
37. Frelinn C, Ladoux A, D'Angelo G. Vascular endothelial growth factors and angiogenesis. Ann Endocrinol (Paris) 61:70-74, 2000.
38. Ray PS, Estrada-Hernandez T, Sasaki H, Zhu L, Maulik N. Early effects of hypoxia/reoxygenation on VEGF, ang-1, ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol Cell Biochem 213:145-153, 2000.
39. Opie LH. Oxygen supply; coronary flow. In: The Heart: Physiology from Cell to Circulation (3rd ed.). Philadelphia: Lippincot-Raven, pp267-93, 1998.
40. Edoute Y, Arieli R, Nevo E. Evidence for improved myocardial oxygen delivery and function during hypoxia in the male heart. J Comp Physiol 158:575-582, 1988.
41. Lauro KL, LaManna JC. Adequacy of cerebral vascular remodeling following three weeks of hypobaric hypoxia. Examined by an integrated composite analytical model. Adv Exp Med Biol 411:369-376, 1997.
42. Prewitt RL, Cardoso SS, Wood WB. Prevention of arteriolar rarefaction in the spontaneously hypertensive rat by exposure to simulated high altitude. J Hypertens 4:735-740, 1986.
43. Brooks D, Horner RL, Kozar LG, Render-Teizeir CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99:106-109, 1997.
44. Fletcher EC, Lesske J, Culman J, Muller CC, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of systemic blood pressure in rats. Hypertension 19:555-561, 1992.
45. Tahawi Z, Orolinova N, Joshua IG, Bader M, Fletcher EC. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 90:2007-2013, 2001.
46. Sica AL, Greenberg HE, Ruggiero DA, Scharf SM. Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. Resp Physiol 121:173-184, 2000.
47. Fletcher EC. Physiological consequences of intermittent hypioxia: systemic blood pressure. J Appl Physiol 90:1600-1605, 2001.
48. Neckář J, Szárszoi O, Herget J, Ošť ádal B, Kolář F. Cardioprotective effect of chronic hypoxia is blunted by concomitant hypercapnia. Physiol Res 52:171-175, 2003.
49. Phillips SA, Olson EB, Morgan BJ, Lombard JH. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286:H388-H393, 2004.
50. Manukhina EB, Mashina SIu, Smirin BV, Lyamina NP, Senchikhin VN, Vanin AF, Malyshev IY. Role of nitric oxide in adaptation to hypoxia and adaptive defense. Physiol Res 49:89-97, 2000.
51. Meerson FZ, Mashina SIu, Lapshin AV, Manukhina EB. Decrease in constrictor response and increase in dilator response of the resistance artery in experimental myocardial infarction: effect of adaptation to hypoxia on this phenomenon [in Russian]. Biull Eksp Biol Med 115:464-466, 1993.
52. Manukhina EB, Lapshin AV, Mashina SIu, Meerson FZ, Mikoian VD. Functional status of endothelium and production of nitric oxide in the rat, adapted to periodic hypoxia [in Russian]. Biull Eksp Biol Med 120:495-498, 1995.
53. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624, 1990.
54. Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, Beguin P, Godin-Ribuot D, Ribuot C, Launois SH, Bessard G, Levy P. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 98:1691-1696, 2005.
55. Obrezchikova MN, Kharchenko IB, Tarasova OS, Koshelev VB. Intermittent hypoxic training in an altitude chamber decelerates but not prevents development of genetically determined hypertension in rats. Hypox Med J 5:3-7, 1997.
56. Melin A, Fauchier L, Dubuis E, Obert P, Bonnet P. Heart rate variability in rats acclimatized to high altitude. High Alt Med Biol 3:375-387, 2003.
57. Pshennikova MG, Malyshev IY, Manukhina EB, Meerson FZ. Distinction between stress resistance and protective effects of adaptation in rats of different genetic strains: Role of regulatory systems. In: Hargens A, Takeda N, Singal PK, Eds. Adaptation Biology and Medicine, Vo 4: Current Concepts. New Delhi: Narosa, pp29-40, 2005.
58. Serebrovskaya TV, Kurhalyuk NM, Nosar VI, Kolesnikova EE. Combination of intermittent hypoxic training with exogenous nitric oxide treatment improves rat liver mitochondrial oxidation and phosphorylation under acute hypoxia. Fiziol. Zh. 47(1):85-92, 2001.
59. Hochachka P, Buck L, Doll C, Land S. Unifying theory of hypoxia tolerance: Molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci U S A 93:9493-9498, 1996.
60. Beguin PC, Joyeux-Faure M, Godin-Ribuot D, Levy P, Ribuot C. Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol 99:1064-1069, 2005
61. Serebrovskaya TV. Intermittent hypoxia research in the former Soviet Union and the Commonwealth of Independent States: History and review of the concept and selected applications. High Alt Med Biol 3:205-221, 2002.
62. Sazontova TG, Arkhipenko YuV, Lukyanova LD. Comparative study of the effect of adaptation to intermittent hypoxia on active oxygen related systems in brain and liver of rats with different resistance to oxygen deficiency. In: Sharma BK, Takeda N, Ganguly NK, Singal PK, Eds. Adaptation Biology and Medicine, Vol 1. New Dehli: Narosa, pp260-266, 1996.
63. Malyshev IY, Zenina TA, Golubeva LY, Saltykova VA, Manukhina EB, Mikoyan VD, Kubrina LN, Vanin AF. NO-dependent mechanisms of adaptation to hypoxia. Nitric Oxide 3:105-113, 1999.
64. Man'kovskaya IN, Vavilova GL, Kharlamova ON, Nosar' VI, Serebrovskaya TV. Activity of the cell membrane marker enzymes in rats under adaptation to hypoxia [in Ukrainian]. Ukr Biochem J 69:9-87, 1997.
65. Dong JW, Zhu HF, Zhu WZ, Ding HL, Ma TM, Zhou ZN. Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res 13:385-391, 2003.
66. Singh S, Evans TW. Nitric oxide, the biological mediator of the decade: fact or fiction? Eur Respir J 10:699-707, 1997.
67. Andrew PJ, Mayer J. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43:521-531, 1999.
68. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem 276:14533-14536, 2001.
69. Moncada S, Higgs A, Furchgott R. International Union of Pharmacology nomenclature in nitric oxide research. Pharmacol Rev 49:137-142, 1997.
70. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74:349-353, 1994.
71. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 91:5212-5216, 1994.
72. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 9:371-377, 1993.
73. Mohaupt MG, Elizie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 46:653-665, 1994.
74. Baylis SA, Weiner CP, Moncada S, Charles IG. In vivo expression of inducible nitric oxide synthase in the human fetus (abstract 3). Presented at the First International Conference on Biochemistry and Molecular Biology of Nitric Oxide, Los Angeles, California, 1994, 66.
75. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol Cell Physiol 271:C1424-C1437, 1996.
76. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356:1-11, 1998.
77. Ronson RS, Nakamura M, Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 44:47-59, 1999.
78. Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30:463-488, 2001.
79. Augusto O, Bonini MG, Amanso AM, Linares E, Santos CCX, De Menezes SL. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med 32:841-859, 2002.
80. Szabó C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140-141:105-112, 2003.
81. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138:532-543, 2003.
82. Postovit L-M, Sullivan R, Adams MA, Graham CH. Nitric oxide signaling and cellular adaptations to changes in oxygenation. Toxicology 208:235-248, 2005.
83. Koppenol WH. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic Biol Med 25:385-391, 1998.
84. Costa NJ, Dahm CC, Hurrell F, Taylor ER, Murphy MP. Interactions of mitochondrial thiols with nitric oxide. Antioxid Redox Signal 5:291-305, 2003.
85. Gaston B. Nitric oxide and thiol groups. Biochim Biophys Acta 1411:323-333, 1999.
86. Wong PS-Y, Hyun J, Fukuto JM, Shirota FN, DeMaster EG, Shoeman DW, Nagasawa HT. Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry 37:5362-5371, 1998.
87. 2 reaction. Chem Res Toxicol 7:519-525, 1994.
88. Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 286:R431-R444, 2004.
89. .-. Free Radic Biol Med 34:1078-1088, 2003.
90. Hogg N. Biological chemistry and clinical potential of S-nitrosothiols. Free Radic Biol Med 28:1478-1486, 2000.
91. Brown GC, Borutaite V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta 1658:44-49, 2004.
92. Arteel GE, Briviba K, Sies H. Protection against peroxynitrite. FEBS Lett 445:226-230, 1999.
93. Gow A, Duran D, Thom SR, Ischiropoulos H. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys 333:42-48, 1996.
94. Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 25:392-403, 1998.
95. Ferdinandy P, Schulz R. Inhibition of peroxynitrite-induced dityrosine formation with oxidized and reduced thiols, nitric oxide donors, and purine derivatives. Antioxid Redox Signal 3:165-171, 2001.
96. Miles AM, Bohle DS, Glassbrenner PA, Hanser B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 271:40-47, 1996.
97. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276:29596-29602, 2001.
98. Wang W, Sawicki G, Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res 53:165-174, 2002.
99. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schöneich C, Cohen RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nature Med 10:1200-1207, 2004.
100. Wink DA, Miranda KM, Katori T, Mancardi D, Thomas DD, Ridnour L, Espey MG, Feelisch M, Colton CA, Fukuto JM, Pagliaro P, Kass DA, Paolocci N. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. Am J Physiol Heart Circ Physiol 285:H2264-H2276, 2003.
101. Shen B, English AM. Mass spectrometric analysis of nitroxyl-mediated protein modification: comparison of products formed with free and protein-based cysteines. Biochemistry 44:14030-14044, 2005.
102. Rengasamy A, Johns RA. Determination of Km for oxygen of nitric oxide synthase isoforms. J Pharmacol Exp Ther 276:30-33, 1996.
103. Abu-Soud HM, Rousseau DL, Stuehr DJ. Nitric oxide binding to the heme of neuronal notric-oxide synthase links its activity to changes in oxygen tension. J Biol Chem 271:32515-32518, 1996.
104. Le Cras TD, McMurty IF. Nitric oxide production in the hypoxic lung. Am J Physiol 280:L575-L582, 2001.
105. Hampl V, Cornfield DN, Cowan NJ, Archer SL. Hypoxia potentiates nitric oxide synthesis and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells. Eur Respir J 8:515-522, 1995.
106. Hampl V, Herget J. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80:1337-1372, 2000.
107. Abu-Soud HM, Wang J, Rousseau DL, Fukuto JM, Ignarro LJ, Stuehr DJ. Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biol Chem 270:22997-23006, 1995.
108. Hurshman AR, Marletta MA. Nitric oxide complexes of inducible nitric oxide synthase: spectral characterization and effect on catalytic activity. Biochemistry 34:5627-5634, 1995.
109. Vanderkooi JM, Erecinska M, Silver IA. Oxygen in mammalian tissue: methods of measurement and affinities of various reactions. Am J Physiol Cell Physiol 260:C1131-C1150, 1991.
110. Heyman SN, Goldfarb M, Darmon D, Brezis M. Tissue oxygenation modifies nitric oxide bioavailability. Microcirculation 6:199-203, 1999.
111. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757-23763, 1993.
112. 2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol 96:1173-1177, 2004.
113. 2 tension. Am J Physiol Cell Physiol 271:C1172-C1180, 1996.
114. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promotor. J Exp Med 182:1683-1693, 1995.
115. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 72:449-489, 1992.
116. 2. Adv Exp Med Biol 410:345-348, 1996.
117. Guo Y, Ward ME, Beasjours S, Mori M, Hussain SNA. Regulation of cerebellar nitric oxide production in response to prolonged in vivo hypoxia. J Neurosci Res 49:89-97, 1997.
118. Kvietikova I, Wenger RH, Marti HH, Gassmann M. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res 23:4542-4550, 1995.
119. Förstermann U, Boissel J-P, Kleinert H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12:773-790, 1998.
120. Gess B, Schricker IK, Pfeifer IM, Kurtz A. Acute hypoxia upregulates NOS gene expression in rats. Am J Physiol Regul Integ Comp Physiol 273:R905-R910, 1997.
121. Coulet F, Nadaud S, Agrapart M, Soubrier F. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 278:46230-46240, 2003.
122. Bickler PE, Donohoe PH. Adaptive responses of vertebrate neurons to hypoxia. J Exp Biol 205:3579-3586, 2002.
123. Turpaev KT. Reactive oxygen species and regulation of gene expression. Biochemistry (Moscow) 67:281-292, 2002.
124. Toporsian M, Govindaraju K, Nagi M, Eidelman D, Thibault G, Ward ME. Downregulation of endothelial nitric oxide synthase in rat aorta after prolonged hypoxia in vivo. Circ Res 86:671-675, 2000.
125. Xue C, Rengasamy A, LeCras TD, Koberna PA, Dailey GC, Johns RA. Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 267:Ll667-LI678, 1994.
126. Shaul PW, North AJ, Brannon TS, Ujiie K, Wells LB, Nisen PA, Lowenstein CJ, Snyder SH, Star RA. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and III gene expression in adult rat lung. Am J Respir Cell Mol Biol 13:167-174, 1995.
127. Le Cras TD, Tyler RC, Horan MP, Morris KG, Tuder RM, McMurtry IF, Johns RA, Abman SH. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase in the adult rat lung. J Clin Invest 101:795-801, 1998.
128. Hoffmann A, Gloe T, Pohl U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J Cell Physiol 188:33-44, 2001.
129. Ziesche R, Petkov V, Williams J, Zakeri SM, Mosgoller W, Knofler M, Block LH. Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue. Proc Natl Acad Sci U S A 93:12478-12483, 1996.
130. Dai A, Zhang Z, Niu R. The effects of hypoxia on nitric oxide synthase activity and mRNA expression of pulmonary artery endothelial cells in pigs [in Chinese]. Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih 18:164-166, 1995.
131. Liao JK, Zulueta JJ, Yu FS, Peng HB, Cote CG, Hassoun PM. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest 96:2661-2666, 1995.
132. Arnet UA, McMillan A, Dinerman JL, Ballermann B, Lowenstein CJ. Regulation of endothelial nitric-oxide synthase during hypoxia. J Biol Chem 271:15069-15073, 1996.
133. Zhang ZG, Chopp M, Zaloga C, Pollock JS, Förstermann U. Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke 24:2016-2021, 1993.
134. Hwang SM, Wilson PD, Laskin JD, Denhardt DT. Age and development-related changes in osteopontin and nitric oxide synthase mRNA levels in human kidney proximal tubule epithelial cells: contrasting responses to hypoxia and reoxygenation. Cell Physiol 160:61-68, 1994.
135. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol Heart Circ Physiol 267:H1921-H1927, 1994.
136. Phelan MW, Faller DV. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. J Cell Physiol 167:469-476, 1996.
137. Daniliuc S, Bitterman H, Rahat MA, Kinarty A, Rosenzweig D, Nitza L. Hypoxia inactivates inducible nitric oxide synthase in mouse macrophages by disrupting its interaction with α-actinin 4. J Immunol 171:3225-3232, 2003.
138. Luckhoff A, Busse R. Refilling of endothelial calcium stores without bypassing the cytosol. FEBS Lett 271:108-110, 1990.
139. Prabhakar NR, Fields RD, Baker T, Fletcher EC. Intermittent hypoxia: cell to system. Am J Physiol Lung Cell Mol Physiol 281:L524-L528, 2001.
140. Dudek SM, Fields RD. Mitogen-activated protein kinase/extracellular signal-regulated kinase activation in somatodendritic compartments: roles of action potentials, frequency and mode of calcium entry. J Neurosci 21:RC122, 2001.
141. Yuan G, Nanduri J, Bhasker CR, Semenza GL, Prabhakar NR. Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 280:4321-4328, 2005.
142. Kabakov AE, Budagova KR, Bryantsev AL, Latchman DS. Heat shock protein 70 or heat shock protein 27 overexpressed in human endothelial cells during posthypoxic reoxygenation can protect from delayed apoptosis. Cell Stress Chaperones 8:335-347, 2003.
143. Kacimi R, Chentoufi J, Honbo N, Long CS, Karliner JS. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc Res 46:139-150, 2000.
144. Patel A, van de Poll MC, Greve JW, Buurman WA, Fearon KC, McNally SJ, Harrison EM, Ross JA, Garden OJ, Dejong CH, Wigmore SJ. Early stress protein gene expression in a human model of ischemic preconditioning. Transplantation 78:1479-1487, 2004.
145. Almgren CM, Olson LE. Moderate hypoxia increases heat shock protein 90 expression in excised rat aorta. J Vasc Res 36:363-371, 1999.
146. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392:821-824, 1998.
147. Pritchard KA Jr., Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, Sessa WC. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitricoxide synthase. J Biol Chem 276:17621-17624, 2001.
148. Shi Y, Baker JE, Zhang C, Tweddell JS, Su J, Pritchard KA Jr. Chronic hypoxia increases endothelial nitric oxide synthase generation of nitric oxide by increasing heat shock protein 90 association and serine phosphorylation. Circ Res 91:300-306, 2002.
149. Chen JX, Meyrick B. Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium. Lab Invest 84:182-190, 2004.
150. Song Y, Zweier JL, Xia Y. Determination of the enhancing action of HSP90 on neuronal nitric oxide synthase by EPR spectroscopy. Am J Physiol Cell Physiol 281:C1819-C1824, 2001.
151. Feinstein DL, Galea E, Aquinao DA, Li GC, Xu H. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation. J Biol Chem 271:17724-17732, 1996.
152. Lau SS, Griffin TM, Mestril R. Protection against endotoxemia by HSP70 in rodent cardiomyocytes. Am J Physiol Heart Circ Physiol 278:H1439-H1445, 2000.
153. Patel VC, Yellon DM, Singh KJ, Neild GH, Woolfson RG. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun 194:234-238, 1993.
154. Depre C, Vanoverschelde JL, Goudemant JF, Mottet I, Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 92:1911-1918, 1995.
155. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemia-reperfusion injury. Cardiovasc Res 30:432-439, 1995.
156. Malyshev IY, Malugin AV, Golubeva LYu, Zenina TA, Manukhina EB, Mikoyan VD, Vanin AF. Nitric oxide donor induces HSP70 accumulation in the heart and in cultured cells. FEBS Lett 391:21-23, 1996.
157. Flogel U, Decking UK, Godecke A, Schrader J. Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice. J Mol Cell Cardiol 31:827-836, 1999.
158. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33:1897-1918, 2001.
159. Zweier JL, Fertmann J, Wei G. Nitric oxide and peroxynitrite in postischemic myocardium. Antioxid Redox Signal 3:11-22, 2001.
160. Cotton JM, Kearney MT, Shah AM. Nitric oxide and myocardial function in heart failure: friend or foe? Heart 88:564-566, 2002.
161. Gourine AV, Bulhak AA, Gonon AT, Pernow J, Sjoquist PO. Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia-reperfusion in vivo. Nitric Oxide 7:210-216, 2002.
162. Bell RM, Maddock HL, Yellon DM. The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart. Cardiovasc Res 57:405-415, 2003.
163. Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J, Keira N, Matoba S, Asayama J, Nakagawa M. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts. Basic Res Cardiol 98:319-328, 2003.
164. Han H, Kaiser R, Hu K, Laser M, Ertl G, Bauersachs J. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts-effects on regional myocardial flow and enzyme release. Basic Res Cardiol 98:165-174, 2003.
165. Li W, Jia G, Guo W, Wang H. Nitric oxide opens second window of protection in ischemic preconditioning via induction of heat-shock protein 72. Chin Med J 116:258-262, 2003.
166. Maejima Y, Adachi S, Ito H, Nobori K, Tamamori-Adachi M, Isobe M. Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity. Cardiovasc Res 59:308-320, 2003.
167. ATP-dependent mechanism. Am J Physiol Heart Circ Physiol 287:H712-H718, 2004.
168. Ding HL, Zhu HF, Dong JW, Zhu WZ, Yang WW, Yang HT, Zhou ZH. Inducible nitric oxide synthase contributes to intermittent hypoxia against
169. du Toit EF, Rossouw E, Salie R, Opie LH, Lochner A Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model. Cardiovasc Drugs Ther 19:23-31, 2005.
170. Wang X, Kevil CG, Gladwin MT, Lefer DJ. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115:1232-1240, 2005.
171. Kitakaze M, Node K, Minamino T, Kosaka H, Shinozaki Y, Mori H, Inoue M, Hori M, Kamada T. Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs. J Am Coll Cardiol 27:1804-1812, 1996.
172. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Inoue M, Tada M, Hori M, Kamada T. Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation 93:356-364, 1996.
173. Pabla R, Curtis MJ. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart. J Mol Cell Cardiol 28:2111-2121, 1996.
174. Pabla R, Buda AJ, Flynn DM, Blesse SA, Shin AM, Curtis MJ, Lefer DJ. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 78:65-72, 1996.
175. Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia. Circulation 86:279-288, 1992.
176. Heusch G, Post H, Michel MC, Kelm M, Schulz R. Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res 87:146-152, 2000.
177. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 75:1086-1095, 1994.
178. Setty S, Tune JD, Downey HF. Nitric oxide contributes to oxygen demand-supply balance in hypoperfused right ventricle. Cardiovasc Res 64:431-436, 2004.
179. Sadoff JD, Scholz PM, Weiss HR. Endogenous basal nitric oxide production does not control myocardial oxygen consumption or function. Proc Soc Exp Biol Med 211:332-338, 1996.
180. Yasmin W, Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 33:422-432, 1997.
181. Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, Mayer B. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 57:55-62, 2003.
182. Malyshev IY, Zenina TA, Golubeva LYu, Saltykova VA, Manukhina EB, Mikoyan VD, Kubrina LN, Vanin AF. NO-dependent mechanisms of adaptation to hypoxia. Nitric Oxide Biol Chem 3:105-113, 1999.
183. Manukhina EB, Malyshev IY. Role of free NO and NO stores in protective effects of adaptation to hypoxia. In: Hargens A, Takeda N, Singal PK, Eds. Adaptation Biology and Medicine, Volume 4: Current Concepts. New Delhi: Narosa, pp82-94, 2005.
184. Llorens S, Nava E. Cardiovascular diseases and the nitric oxide pathway. Curr Vasc Pharmacol 1:335-46, 2003.
185. Muller B, Kleschyov AL, Gyorgy K, Stoclet J-C. Inducible NO synthase activity in blood vessels and heart: new insight into cell origin and consequences. Physiol Res 49:1-26, 2000.
186. Wiest R, Shah V, Sessa WC, Groszmann RJ. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol Gastrointest Liver Physiol 276:G1043-1051, 1999.
187. Vanin AF, Lapshin AV, Manukhina EB, Meerson FZ. Increased nitric oxide synthesis by rat aorta in experimental myocardial infarction. In: Moncada S, Feelish M, Busse R, Higgs EA, Eds. The Biology of Nitric Oxide, Part 3: Clinical and Physiological Aspects. London: Portland Press, pp96-99, 1994.
188. Zong P, Ryou M-G, Sun W, Sharma, AB, Sun J, Downey HF, Mallet RT. Intermittent hypoxic conditioning suppresses nitric oxide synthase activity in canine myocardium. FASEB J 19:A709, 2005.
189. Stoclet JC, Muller B, Andriantsitohaina R, Kleschyov AL. Over-production of nitric oxide in pathophysiology of blood vessels. Biochemistry (Moscow) 63:976-983, 1998.
190. Mitsuhata H, Takeuchi H, Saitoh J, Hasome N, Noriguchi N, Shimizu R. An inhibitor of nitric oxide synthase, N-(omega)-nitro-L-arginine-methyl ester, attenuates hypotension but does not improve cardiac depression in anaphylaxis in dogs. Shock 3:447-453, 1995.
191. Manukhina EB, Azamatov ZZ, Malyshev IY. Effect of heat shock on the endothelium-mediated reactions in the isolated rat aorta [in Russian]. Biull Eksp Biol Med 122:148-151, 1996.
192. Hall DM, Buettner GR, Oberley LW, Xu L, Matthes RD, Gisolfi CV. Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia. Am J Physiol Heart Circ Physiol 280:H509-H521, 2001.
193. Koch MA, Hasser EM, Schadt JC. Influence of nitric oxide on the hemodynamic response to hemorrhage in conscious rabbits. Am J Physiol Regul Integ Comp Physiol 268:R171-R182, 1995.
194. Manukhina EB, Lapshin AV, Meerson FZ. Adaptation to intermittent hypoxia prevents disorders of endothelium-dependent relaxation and fall of blood pressure in experimental myocardial infarction. Hypox Med J 1:15-18, 1994.
195. Hochman JS. Cardiogenic shock complicating acute myocardial infarction Circulation 107:2998-3002, 2003.
196. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338:1555-1557, 1991.
197. Pokidyshev DA, Bondarenko NA, Malyshev IY, Mikoian VD, Kubrina LN, Vanin AF, Manukhina EB. Selective inhibition of inducible NO-synthase by nonselective inhibitor [in Russian]. Ross Fiziol Zh Im I M Sechenova 84:1420-1427, 1998.
198. Hotchkiss RS, Karl IE, Parker JL, Adams HR. Inhibition of NO synthesis in septic shock. Lancet 339:434-435, 1992.
199. Mulder MF, Van Lambalgen AA, Huisman E, Visser JJ, Van den Bos GC, Thijs LG. Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol Heart Circ Physiol 266:H1558-H1564, 1994.
200. Klabunde RE, Ritger RC. NG-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 178:1135-1140, 1991.
201. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57, 1992.
202. Manukhina EB, Pokidyshev DA, Malyshev IY. Prevention of acute hypotension and endothelial overactivation in heat shock by adaptation to stress exposure [in Russian]. Biull Eksp Biol Med 124:380-384, 1997.
203. Manukhina EB, Malyshev IY, Mikoyan VD, Kubrina LN, Vanin AF. Increase of nitric oxide production in rat organs in heat shock [in Russian]. Biull Eksp Biol Med 121:520-523, 1996.
204. Manukhina EB, Lapshin AV, Meerson FZ. Effect of adaptation to periodic hypoxia on post-infarction fall of blood pressure and hyperactivation of the endothelium [in Russian]. Fiziol Zh 37:98-105, 1991.
205. Meerson FZ, Manukhina EB, Lapshin AV, Ustinova EE. Correlation between the endothelium-dependent relaxation of the aorta and arterial pressure in rats with myocardial infarction [in Russian]. Biull Eksp Biol Med 108:21-24, 1989.
206. Manukhina EB, Pokidyshev DA, Smirin BV, Malyshev IY, Mikoyan VD, Kubrina LN, Vanin AF. Nitric oxide as a factor of organism defence in extreme conditions. Role of nitric monooxide in vital processes [in Russian]. Minsk Polibig 203-205, 1998.
207. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5:834-842, 1992.
208. Stoclet JC, Troncy E, Muller B, Brua C, Kleschyov AL. Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system. Exp Opin Invest Drugs 7:1769-1779, 1998.
209. Szabo C, Dawson VL. Role of poly(ADP-riboso)synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19:287-298, 1998.
210. Lind L, Granstam SO, Millgard J. Endothelium-dependent vasodilation in hypertension: a review. Blood Press 9:4-15, 2000.
211. Newaz MA, Nawal NN, Rohaizan CH, Muslim N, Gapor A. Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. Am J Hypertens 12:839-844, 1999.
212. Borgonio A, Witte K, Stahrenberg R, Lemmer B. Influence of circadian time, ageing, and hypertension on the urinary excretion of nitric oxide metabolites in rats. Mech Ageing Dev 111:23-37, 1999.
213. Chou TC, Yen MH, Ding YA. Alterations of nitric oxide synthesis with aging and hypertension in rats. Hypertension 31:643-648, 1998.
214. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26:854-857, 1995.
215. Parenti A, Filippi S, Amerini S, Granger HJ, Fazzini A, Ledda F. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol. J Pharmacol Exp Ther 292:698-703, 2000.
216. Buval'tsev VI, Mashina SIu, Pokidyshev DA, Smirin BV, Bayda LA, Malyshev IY, Manukhina EB. Implication of correcting nitric oxide metabolism in the organism for prevention of hypertensive remodeling in the cardiovascular system [in Russian]. Ross Kardiol Z 37:74-81, 2002.
217. Buval'tsev VI, Spasskaia MB, Nebieridze DV, Metel'skaia VA, Guseva OI.. Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction [in Russian]. Klin Med (Mosk) 81:51-55, 2003.
218. Smirin BV, Pokidyshev DA, Malyshev IY, Vanin AF, Manukhina EB. Nitric oxide storage as a factor of adaptive defense [in Russian]. Ross Fiziol Zh Im I M Sechenova 86:447-454, 2000.
219. Malyshev IY, Manukhina EB. Stress, adaptation and nitric oxide. Biochemistry (Moscow) 63:840-853, 1998.
220. Manukhina EB, Malyshev IY. Role of nitric oxide in protective effects of adaptation. In: Moravec J, Takeda N, Singal PK, Eds. Adaptation Biology and Medicine, Volume 3. New Delhi: Narosa, pp312-327, 2002.
221. Kolář F, Ošťádal B. Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. Physiol Res 53:S3-S13, 2004.
222. Bolli R. The late phase of preconditioning. Circ Res 87:972-983, 2000.
223. Neckář J, Papoušek F, Nováková O, Ošt'ádal B, Kolář F. Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive. Basic Res Cardiol 97:161-167, 2002.
224. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72:1293-1299, 1993.
225. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88:1264-1272, 1993.
226. Milano G, Corno AF, Lippa S, von Segesser LK, Samaja M. Chronic and intermittent hypoxia induce different degrees of myocardial tolerance to hypoxia-induced dysfunction. Exp Biol Med 227:389-397, 2002.
227. ATP channels. Exp Biol Med 229:1196-1205, 2004.
228. ATP challel blockade does not abolish increased RV tolerance to ischemia. Am J Physiol Heart Circ Physiol 286:H545-H551, 2004.
229. Ošt'ádalová I, Ošt'ádal B, Jarkovská D, Kolář F. Ischemic preconditioning in chronically hypoxic neonatal rat heart. Pediatr Res 52:561-567, 2002.
230. Rouet-Benzineb P, Eddahibi S, Raffestin B, Laplace M, Depond S, Adnot S, Crozatier B. Induction of cardiac nitric oxide synthase 2 in rats exposed to chronic hypoxia. J Mol Cell Cardiol 31:1697-1708, 1999.
231. Kolář F, Szárszoi O, Neckář J, Pechánová O, Miková D, Hampl V, Ošt'ádal B. Role of nitric oxide and reactive oxygen species in reperfusion-induced arrhythmias and cardioprotection in chronically hypoxic rat hearts. Physiol Res 52:52P, 2003.
232. Grilli A, De Lutiis AM, Patruno A, Speranza L, Gizzi F, Taccardi AA, Napoli P, De Caterina R, Conti P, Felaco M. Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. Am Clin Lab Sci 33:208-215, 2003.
233. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A 96:11507-11512; 1999.
234. Parratt JR, Szekeres L. Delayed protection of the heart against ischemia. Trends Pharmacol Sci 16:351-355, 1995.
235. Song W, Furman BL, Parratt JR. Delayed protection against ischemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin. Br J Pharmacol 118:2157-2163, 1996.
236. Gyorgy K, Muller B, Vegh A, Kleschyov AL, Stoclet JC. Triggering role of nitric oxide in the delayed protective effect of monophosphoryl lipid A in rat heart. Br J Pharmacol. 127:1892-1898, 1999.
237. Vanin AF. Dinitrosyl iron complexes and S-nitrosothiols: two possible forms of nitric oxide stabilization and transport in biological systems. Biochemistry (Moscow) 63:782-796, 1998.
238. Manukhina EB, Smirin BV, Malyshev IY, Stoclet JC, Muller B, Solodkov AP, Shebeko VI, Vanin AF. Nitric oxide storage in the cardiovascular system. Biol Bull 29:477-486, 2002.
239. Vanin AF, Kleschyov AL. EPR detection and biological implication of nitrosyl non-heme iron complexes. In: Lukiewicz SJ, Zweier JL, Eds. Nitric Oxide in Transplant Rejection and Anti-Tumor Defense. Norwell, MA: Kluwer, pp49-82, 1998.
240. Flitney FW, Megson IL, Flitney DE, Butler AR. Iron-sulphur cluster nitrosyls, a novel class of nitric oxide generator: mechanism of vasodilator action on rat isolated tail artery. Br J Pharmacol 107:842-848, 1992.
241. Alencar JL, Lobysheva I, Geffard M, Sarr M, Schott C, Schini-Kerth VB, Nepveu O, Stoclet JC, Muller B. Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone. Mol Pharmacol 63:1148-1158, 2003.
242. Megson IL, Holme SA, Magid KS. Selective modifiers of glutathione biosynthesis and 'repriming' of vascular smooth muscle photo-relaxation. Br J Pharmacol 130:1575-1580, 2000.
243. Smirin BV, Vanin AF, Malyshev IY, Pokidyshev DA, Manukhina EB. Nitric oxide storage in blood vessels in vivo [in Russian]. Biull Eksp Biol Med 127:629-632, 1999.
244. Muller B, Kleschyov AL, Stoclet JC. Evidence for N-acetylcysteine- sensitive nitric oxide storage as dinitrosyl iron complexes in lipopolysaccharide-treated rat aorta. Br J Pharmacol 119:1281-1285, 1996.
245. Manukhina EB, Malyshev IY, Smirin BV, Mashina SIu, Saltykova VA, Vanin AF. Production and storage of nitric oxide in adaptation to hypoxia. Nitric Oxide 3:393-401, 1999.
246. Manukhina EB, Mashina SIu, Vlasova MA, Smirin BV, Pokidyshev DA, Malyshev IY. Role of free NO and NO stores in cardiovascular adaptation to hypoxia [in Russian]. Region Krovoobr Mikrocirk 3:4-11, 2004.
247. Muller B, Kleschyov AL, Malblanc S, Stoclet JC. Nitric oxide-related cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopolysaccharide-treated rat aorta. Br J Pharmacol 123:1221-1229, 1998.
248. Vlasova MA, AF, Muller B, Smirin BV, Malyshev IY, Manukhina EB. Detection and description of various pools of nitric oxide store in vascular wall. Bull Exp Biol Med 136:226-230, 2003.
249. Kolar F, Szarszoi O, Neckar J, Ostadal B. Improved cardiac ischemic tolerance in rats adapted to chronic hypoxia is reduced by simultaneous treatment with N-acetylcysteine. Eur J Heart Fail, Suppl 2/1:46, 2003.
250. Wu CC, Yen MH. Nitric oxide synthase in spontaneously hypertensive rats. Biomed Sci 4:249-255, 1997.
251. Luchsinger BP, Rich EN, Gow AJ, Williams EM, Stamler JS, Singel DJ. Routes to S-nitroso-hemoglobin formation with heme redox and preferential reactivity in the B subunits. Proc Natl Acad Sci U S A 100:461-466, 2003.
252. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276:2034-2037, 1997.
253. Buehler PW, Alayash AI. Oxygen sensing in the circulation: "cross talk" between red blood cells and the vasculature. Antioxid Redox Signal 6:1000-1010, 2004.
254. Joshi MS, Ferguson TB Jr., Han TH, Hyduke DR, Liao JC, Rassaf T, Bryan N, Feelisch M, Lancaster JR Jr. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci U S A 99:10341-10346, 2002.
255. 2/NO-linked allosteric function. J Biol Chem 277:27818-27828, 2002.
256. Vaughn MW, Huang KT, Kuo L, Liao JC. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem 275:2342-2348, 2000.
257. Huang Z, Louderback JG, Goyal M, Azizi F, King SB, Kim-Shapiro DB. Nitric oxide binding to oxygenated hemoglobin under physiologic conditions. Biochim Biophys Acta 1568:252-260, 2001.
258. Liu X, Miller MJS, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster JR Jr. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 273:18709-18713, 1998.
259. Liao JC, Hein TW, Vaughn MW, Huang KT, Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci U S A 96:8757-8761, 1999.
260. Dejam A, Hunter CJ, Schechter AN, Gladwin MT. Emerging role of nitrite in human biology. Blood Cells Mol Dis 32:423-429, 2004.
261. Reutov VP, Sorokina EG. NO-synthase and nitrite-reductase components of nitric oxide cycle. Biochemistry (Moscow) 63:874-884, 1998.
262. Lundberg JO, Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol 25:915, 2005.
263. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739-749, 1981.
264. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 427:225-228, 1998.
265. Demoncheaux EAG, Higenbottam TW, Foster PJ, Borland CDR, Smith APL, Marriott HM, Bee D, Akamine S, Davies MB. Circulating nitrite anions are a directly acting vasodilator and are donors for nitric oxide. Clin Sci 102:77-83, 2002.
266. Li H, Samouilov A, Liu X, Zweier JL. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem 276:24482-24489, 2001.
267. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJ. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115:1232-1240, 2005.
268. Tsuchiya K, Kanematsu Y, Yoshizumi M, Ohnishi H, Kirima K, Izawa Y, Shikishima M, Ishida T, Kondo S, Kagami S, Takiguchi Y, Tamaki T. Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol 288:H2163-H2170, 2005.
269. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Toxicol 30:535-560, 1990.
270. Bredt DS, Snyder SH. Nitric oxide, a physiological messenger molecule. Annu Rev Biochem 63:175-195, 1994.
271. Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, Mayer B. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 57:55-62, 2003.
272. ATP channel. Circulation 95:1278-1285, 1997.
273. Lyamina NP, Senchikhin VN, Pokidyshev DA, Manukhina EB. Impaired NO production in young men with arterial hypertension and a non-drug method for its correction [in Russian]. Kardiologiya 9:17-21, 2001.
274. Lyamina NP, Dolotovskaya PV, Lyamina SV, Malyshev IY, Manukhina EB. Nitric oxide production and intensity of free radical processes in young men with high normal and hypertensive blood pressure. Med Sci Monit 9:CR304-310, 2003.
275. Earley S, Walker BR. Increased nitric oxide production following chronic hypoxia contributes to attenuated systemic vasoconstriction. Am J Physiol Heart Circ Physiol 284:H1655-H1661, 2003.
276. Earley S, Walker BR. Endothelium-dependent blunting of myogenic responsiveness following chronic hypoxia. Am J Physiol Heart Circ Physiol 283:H2202-H2209, 2002.
277. Earley S, Naik JS, Walker BR. 48-h Hypoxic exposure results in endothelium-dependent systemic vascular smooth muscle cell hyperpolarization. Am J Physiol Regul Integr Comp Physiol 283:R79-R85, 2002.
278. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275:21722-21729, 2000.
279. Chitaley K, Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling. Hypertension 39:438-442, 2002.
280. 2+ influx. Circ Res 84:210-219, 1999.
281. Paolocci N, Ekelund UE, Isoda T, Ozaki M, Vandegaer K, Georgakopoulos D, Harrison RW, Kass DA, Hare JM. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. Am J Physiol Heart Circ Physiol 279:H1982-H1988, 2000.
282. Malyshev IY, Aymasheva NP, Malenyuk EB, Manukhina EB, Khaspekov GL, Mikoyan VD, Kubrina LN, Vanin AF. Nitric oxide increases gene expression of Ca(2+)-ATPase in myocardial and skeletal muscle sarcoplasmic reticulum: physiological implications. Med Sci Monit 6:480-485, 2000.
283. 2+ pump of the cardiac sarcoplasmic reticulum and its resistance to endogenous damaging factors [in Russian]. Kardiologiia 32:57-61, 1992.
284. Sazontova TG, Arkhipenko YuV. Membranoprotective effects of adaptation in the heart and skeletal muscles. In: Hargens A, Takeda N, Signal PK, Eds. Adaptation Biology and Medicine. Volume 4: Current Concepts. New Delhi: Narosa, pp112-123, 2005.
285. Xu KY, Kuppusamy SP, Wang JQ, Li H, Cui H, Dawson TM, Huang PL, Burnett AL, Kuppusamy P, Becker LC. Nitric oxide protects cardiac sarcolemmal membrane enzyme function and ion active transport against ischemia-induced inactivation. J Biol Chem 278:41798-41803, 2003.
286. Pfeilschifter J, Eberhardt W, Beck KF. Regulation of gene expression by nitric oxide. Pflügers Arch 442:479-486, 2001.
287. Brune B, Zhou J. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1α (HIF-1α). Curr Med Chem 10:845-855, 2003.
288. Kasuno K, Takabuchi S, Fukuda K, Kizaka-Kondoh S, Yodoi J, Adachi T, Semenza GL, Hirota K. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signalling. J Biol Chem 279:2550-2558, 2004.
289. Yasinska IM, Sumbayev VV. S-nitrosation of Cys-800 of HIF-1 alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett 549:105-109, 2003.
290. Brune B, von Knethen A, Sandau KB. Transcription factors p53 and HIF-1alpha as targets of nitric oxide. Cell Signal 13:525-533, 2001.
291. Natarajan R, Fisher BJ, Fowler AA 3rd. Regulation of hypoxia inducible factor-1 by nitric oxide in contrast to hypoxia in microvascular endothelium. FEBS Lett 549:99-104, 2003.
292. Wang F, Sekine H, Kikuchi Y, Takasaki C, Miura C, Heiwa O, Shuin T, Fujii-Kuriyama Y, Sogawa K. HIF-1alpha-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathway. Biochem Biophys Res Commun 295:657-662, 2002.
293. Agani FH, Puchowicz M, Chavez JC, Pichiule P, LaManna J. Role of nitric oxide in the regulation of HIF-1alpha expression during hypoxia. Am J Physiol Cell Physiol 283:C178-C186, 2002.
294. Manukhina EB, Buvaltsev VI, Pokidyshev DA, Smirin BV, Mashina SIu. Antihypertensive efficacy of adaptation to intermittent hypoxia vs. beta-blocker and NO donor therapy: role of nitric oxide. Hypox Med J 11:34, 2003.
295. Buval'tsev VI, Bayda LA, Pokidyshev DA, Smirin BV, Manukhina EB, Malyshev IY. State of the self-defense "NO-HSP70" system in genetically hypertensive and normotensive rats and possibilities of its modulation with current beta-blockers [in Russian]. Ross Kardiol Z 37:72-79, 2002.
296. Dulak J, Jozkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, Florek I, Wojtowicz A, Szuba A, Cooke JP. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:659-666, 2000.
297. Frank S, Stallmeyer B, Kämpfer H, Kolb N, Pfeilschifter J. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 13:2002-2014, 1999.
298. LaManna JC, Chavez JC, Pichiule P. Structural and functional adaptation to hypoxia in the rat brain. J Exp Biol 207:3163-3169, 2004.
299. Dulak J, Jozkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal 5:123-132, 2003.
300. Xu Q, Hu Y, Kleindienst R, Wick G. Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1. J Clin Invest 100:1089-1097, 1997.
301. Stuhlmeier KM. Activation and regulation of Hsp32 and Hsp70. Eur J Biochem 267:1161-1167, 2000.
302. Trost SU, Omens JH, Karlon WJ, Meyer M, Mestril R, Covell JW, Dillmann WH. Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70. J Clin Invest 101:855-862, 1998.
303. Kim YM, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272:1402-1411, 1997.
304. Mosser DD, Caron AW, Bourget L, Denis-Laose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 17:5317-5327, 1997.
305. Wang JHPRH, Watson WG, Condron C, Bouchier-Hayes D. Induction of heat shock protein 72 prevents neutrophil-mediated human endothelial cell necrosis. Arch Surg 130:1260-1265, 1995.
306. Dhakshinamoorthy S, Porter AG. Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J Biol Chem 279:20096-20107, 2004.
307. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, Bach FH. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nature Med 4:1073-1077, 1998.
308. Vile GF, Basu-Modak S, Waltner C, Tyrell RM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci U S A 91:2607-2610, 1994.
309. Lee PJ, Alam J, Wiegand GW, Choi AM. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci U S A 93:10393-10398, 1996.
310. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 90:7240-7244, 1993.
311. Uno H, Arakawa T, Fukuda T, Fujiwara HYY, Higuchi K, Inoue M, Kobayashi K. Nitric oxide stimulates prostaglandin synthesis in cultured rabbit gastric cells. Prostaglandins 53:153-162, 1997.
312. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 105:1631-1639, 2000.
313. Kim YM, Chung HT, Kim SS, Han JA, Yoo YM, Kim KM, Lee GH, Yun HY, Green A, Li JR, Simmons RL, Billiar TR. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci 19:6740-6747, 1999.
314. L induced in activated macrophages. J Immunol 160:2590-2596, 1998.
315. Ciani E, Guidi S, Della Valle G, Perini G, Bartesaghi R, Contestabile A. Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation. J Biol Chem 277:49896-49902, 2002.
316. Choi BM, Pae HO, Chung HT. Nitric oxide priming protects nitric oxide-mediated apoptosis via heme oxygenase-1 induction. Free Radic Biol Med 34:1136-1145, 2003.